Company Monitoring Page for Exelixis

latest headlines for company on cafepharma

Exelixis keeps cards close
Minyanville
Thu, 05/19/11 - 01:53 pm
Tags:
Exelixis, cabozantinib
Exelixis: Looming Cancer Conference a Favorable Swing Trade Opportunity
Seeking Alpha
Mon, 05/16/11 - 09:33 am
Tags:
Exelixis, cancer, tyrosine kinases
Ariad and Exelixis Look to Shine at Upcoming Trade Show
Seeking Alpha
Thu, 05/12/11 - 11:48 am
Tags:
Ariad Pharmaceuticals, Exelixis, ridaforolimus, cancer, cabozantinib
Exelixis' CEO Discusses Q1 2011 Results - Earnings Call Transcript
Seeking Alpha
Wed, 05/4/11 - 09:57 am
Tags:
earnings, Exelixis
Exelixis spurs takeover rumors with Goldman ploy
Fierce Biotech
Tue, 04/12/11 - 10:05 am
Tags:
prostate cancer, Exelixis, cabozantinib
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
Tags:
cancer, Carfilzomib, crizotinib, vismodegib, Oncovex, PLX4032, Ponatinib, SGN-35, tivozanib, T-DM1, cabozantinib, ONYX Pharmaceuticals, Pfizer, Genentech, Curis, Amgen, Plexxikon, Seattle Genetics, Ariad Pharmaceuticals, Aveo Pharmaceutical, Exelixis, Roche
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 04/4/11 - 11:06 pm
Tags:
Gilead Sciences, Exelixis, Amgen, Dendreon, Immunogen, Maxygen, MannKind, PDL Biopharma, Celgene, Geron, Vertex Pharmaceuticals, Arena Pharmaceuticals, Human Genome Sciences, Orexigen, Biogen Idec
Cancer Drug Stocks to Trade Ahead of ASCO
TheStreet.com
Tue, 03/22/11 - 10:03 am
Tags:
ASCO, Medivation, Exelixis, Dendreon, Bristol-Myers Squibb, Roche, Curis, Celgene, Sanofi, Ariad Pharmaceuticals, Merck, Incyte, Novartis, YM BioSciences, Pfizer, Aveo Pharmaceutical, ONYX Pharmaceuticals, Amgen, Synta, Vical, Oxigene, Cell Therapeutics, Oncothyreon
Exelixis plans $165M stock sale
Bizjournals.com
Thu, 03/10/11 - 10:23 am
Tags:
Exelixis, stock offering
Exelixis Slides on Stock Sale Plans
TheStreet.com
Tue, 03/8/11 - 07:57 am
Tags:
stock offering, Exelixis
Battered but Unbroken Biotechs
Seeking Alpha
Tue, 03/1/11 - 10:26 am
Tags:
Amylin, Alnylam, Celldex, Exelixis, Human Genome Sciences, Isis Pharmaceuticals, Lexicon Pharmaceuticals, Neurocrine, Nektar, ONYX Pharmaceuticals, Ziopharm, Seattle Genetics
Exelixis: Going Where No Drug Has Gone Before
Seeking Alpha
Wed, 02/23/11 - 10:47 pm
Tags:
Exelixis, cabozantinib, prostate cancer
Exelixis Q4 loss narrows to $17.9M
Yahoo/AP
Wed, 02/23/11 - 08:06 am
Tags:
earnings, Exelixis
Exelixis seen narrowing Q4 loss, increasing revenue
Bizjournals.com
Tue, 02/22/11 - 09:28 am
Tags:
earnings, Exelixis
Exelixis shares rise after report on cancer drug
Yahoo/AP
Sat, 02/19/11 - 11:38 am
Tags:
Exelixis, prostate cancer, cabozantinib
Top Biotech Takeout Targets in 2011
Minyanville
Fri, 02/18/11 - 03:32 pm
Tags:
M&A, biotech, Biogen Idec, Human Genome, Seattle Genetics, GSK, Dendreon, Actelion, Biomarin, Exelixis, Vertex Pharmaceuticals, Celgene, Alexion, Shire, InterMune, Lexicon Pharmaceuticals, Savient, Merck KGaA
Exelixis: A Successful Development Stage Biotech Firm
Seeking Alpha
Mon, 02/14/11 - 05:56 pm
Tags:
Exelixis
Value Investing, Biotech Style
Motley Fool
Sat, 01/29/11 - 11:35 am
Tags:
investors, Benlysta, Human Genome Sciences, GSK, Cell Therapeutics, obesity. Orexigen Therapeutics, Vertex Pharmaceuticals, Exelixis
Smart Money's 9 Top Biotech Stock Picks
Seeking Alpha
Mon, 01/17/11 - 12:53 pm
Tags:
biotech, Cadence Pharmaceuticals, Cell Therapeutics, Enzon, Geron, Exelixis, Seattle Genetics, Savient, Vivus, Theravance
Exelixis cancer drug wins 'orphan' tag
Bizjournals.com
Mon, 01/10/11 - 12:35 pm
Tags:
Exelixis, orphan drugs, XL-184, thyroid cancer

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.